Stromal disrupting effects of nab-paclitaxel in pancreatic cancer von Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, P P, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, de Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F, Hidalgo, M

Volltext

Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer’ von Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, P P, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, de Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F, Hidalgo, M

Volltext

The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V von Coma, S., Musteanu, M., Mira, A., Caffarra, C., Morrison, D., Ambrogio, C., Barbacid, M., Pachter, J.

Volltext

363 ROLE OF GROWTH HORMONE RECEPTOR IN LIVER FIBROSIS von Stiedl, P, Blaas, L, Stanek, V, Musteanu, M, Zollner, G, Esterbauer, H, Eferl, R, Trauner, M, Casanova, E

Volltext

PO-211 KRAS driven lung adenocarcinoma depends on ERBB signalling von Moll, HP, Pranz, K, Musteanu, M, Grabner, B, Hruschka, N, Mohrherr, J, Barbacid, M, Dome, B, Popper, H, Casanova, E

Volltext

7018 POSTER NFkB Activity Modulates the Oncogenic Potential of Stat3 in Prostate Cancer Development von Pencík, J, Schlederer, M, Mair, M, Musteanu, M, Poli, V, Eferl, R, Moriggl, R, Culig, Z, Kenner, L

Volltext

P52.05 Dual RAF/MEK Inhibitor VS-6766 for Treatment of KRAS Mutant NSCLC: Novel Combinations Targeting G12C or G12V Variants von Coma, S., Chowdhury, S., Musteanu, M., Stewart, A., Pickard, L., Krebs, M., Minchom, A., Banerji, U., Barbacid, M., Pachter, J.

Volltext

Dissecting the roles of Fra proteins in lung adenocarcinoma von Alfraidi, A., Bakiri, L., Ucero, A., Musteanu, M., Barbacid, M., Wagner, E.

Volltext

A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions von Moll, Herwig P, Mohrherr, Julian, Blaas, Leander, Musteanu, Monica, Stiedl, Patricia, Grabner, Beatrice, Zboray, Katalin, König, Margit, Stoiber, Dagmar, Rülicke, Thomas, Strehl, Sabine, Eferl, Robert, Casanova, Emilio

Volltext

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends von Aytekin, Metin, Vinatzer, Ursula, Musteanu, Monica, Raynaud, Sophie, Wieser, Rotraud

Volltext

Supplementary files of the article KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors [Dataset] von Paniagua, Guillem, Jacob, Harrys K.C., Brehey, Oksana, Garc??A-Alonso, Sara, Lechuga, Carmen G., Pons, Tirso, Musteanu, M??Nica, Guerra, Carmen, Drosten, Matthias, Barbacid, Mariano

Volltext bestellen

Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation von García-Alonso, Sara, Mesa, Pablo, Ovejero, Laura de la Puente, Aizpurua, Gonzalo, Lechuga, Carmen G., Zarzuela, Eduardo, Santiveri, Clara M., Sanclemente, Manuel, Muñoz, Javier, Musteanu, Mónica, Campos-Olivas, Ramón, Martínez-Torrecuadrada, Jorge, Barbacid, Mariano, Montoya, Guillermo

Volltext

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis von Rodrigo-Faus, Maria, Vincelle-Nieto, Africa, Vidal, Natalia, Puente, Javier, Saiz-Pardo, Melchor, Lopez-Garcia, Alejandra, Mendiburu-Eliçabe, Marina, Palao, Nerea, Baquero, Cristina, Linzoain-Agos, Paula, Cuesta, Angel M., Qu, Hui-Qi, Hakonarson, Hakon, Musteanu, Monica, Reyes-Palomares, Armando, Porras, Almudena, Bragado, Paloma, Gutierrez-Uzquiza, Alvaro

Volltext

ERK Inhibitor LY3214996-Based Treatment Strategies for RAS -Driven Lung Cancer von Köhler, Jens, Zhao, Yutong, Li, Jiaqi, Gokhale, Prafulla C, Tiv, Hong L, Knott, Aine R, Wilkens, Margaret K, Soroko, Kara M, Lin, Mika, Ambrogio, Chiara, Musteanu, Monica, Ogino, Atsuko, Choi, Jihyun, Bahcall, Magda, Bertram, Arrien A, Chambers, Emily S, Paweletz, Cloud P, Bhagwat, Shripad V, Manro, Jason R, Tiu, Ramon V, Jänne, Pasi A

Volltext